1	Use	Use	B-NP	NN	O	0	ROOT	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	uteroglobin	uteroglobin	B-NP	NN	O	2	PMOD	0
4	for	for	B-PP	IN	O	1	NMOD	0
5	the	the	B-NP	DT	O	6	NMOD	0
6	engineering	engineering	I-NP	NN	O	4	PMOD	0
7	of	of	B-PP	IN	O	6	NMOD	0
8	polyvalent	polyvalent	B-NP	JJ	O	7	PMOD	0
9	,	,	I-NP	,	O	8	P	0
10	polyspecific	polyspecific	I-NP	JJ	B-protein	12	NMOD	0
11	fusion	fusion	I-NP	NN	I-protein	12	NMOD	0
12	proteins	protein	I-NP	NNS	I-protein	8	NMOD	0
13	.	.	O	.	O	1	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	report	report	B-VP	VBP	O	0	ROOT	0
3	a	a	B-NP	DT	O	5	NMOD	0
4	novel	novel	I-NP	JJ	O	5	NMOD	0
5	strategy	strategy	I-NP	NN	O	2	OBJ	0
6	to	to	B-PP	TO	O	5	NMOD	0
7	engineer	engineer	B-NP	NN	O	6	PMOD	0
8	and	and	O	CC	O	2	VMOD	0
9	express	express	B-VP	VBP	O	2	VMOD	0
10	stable	stable	B-NP	JJ	O	12	AMOD	0
11	and	and	I-NP	CC	O	12	AMOD	0
12	soluble	soluble	I-NP	JJ	O	9	OBJ	0
13	human	human	I-NP	JJ	B-protein	15	AMOD	0
14	recombinant	recombinant	I-NP	JJ	I-protein	15	AMOD	0
15	polyvalent/polyspecific	polyvalent/polyspecific	I-NP	JJ	I-protein	12	NMOD	0
16	fusion	fusion	I-NP	NN	I-protein	17	NMOD	0
17	proteins	protein	I-NP	NNS	I-protein	12	NMOD	0
18	.	.	O	.	O	2	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	procedure	procedure	I-NP	NN	O	3	SUB	0
3	is	be	B-VP	VBZ	O	0	ROOT	0
4	based	base	I-VP	VBN	O	3	VC	0
5	on	on	B-PP	IN	O	4	VMOD	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	use	use	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	a	a	B-NP	DT	O	11	NMOD	0
10	central	central	I-NP	JJ	O	11	NMOD	0
11	skeleton	skeleton	I-NP	NN	O	8	PMOD	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	uteroglobin	uteroglobin	B-NP	NN	B-protein	19	NMOD	0
14	,	,	O	,	O	19	P	0
15	a	a	B-NP	DT	O	16	NMOD	0
16	small	small	I-NP	JJ	O	19	NMOD	0
17	and	and	O	CC	O	19	AMOD	0
18	very	very	B-ADJP	RB	O	19	AMOD	0
19	soluble	soluble	I-ADJP	JJ	O	21	AMOD	0
20	covalently	covalently	B-VP	RB	O	21	AMOD	0
21	linked	link	I-VP	VBN	O	23	NMOD	0
22	homodimeric	homodimeric	B-NP	JJ	B-protein	23	NMOD	0
23	protein	protein	I-NP	NN	I-protein	12	PMOD	0
24	that	that	B-NP	WDT	O	23	NMOD	0
25	is	be	B-VP	VBZ	O	24	SBAR	0
26	very	very	B-ADJP	RB	O	27	AMOD	0
27	resistant	resistant	I-ADJP	JJ	O	25	PRD	0
28	to	to	B-PP	TO	O	27	AMOD	0
29	proteolytic	proteolytic	B-NP	JJ	B-protein	30	NMOD	0
30	enzymes	enzyme	I-NP	NNS	I-protein	28	PMOD	0
31	and	and	B-PP	CC	O	28	PMOD	0
32	to	to	B-PP	TO	O	28	PMOD	0
33	pH	pH	B-NP	NN	O	34	NMOD	0
34	variations	variation	I-NP	NNS	O	32	PMOD	0
35	.	.	O	.	O	3	P	0

1	Using	Use	B-VP	VBG	O	33	VMOD	0
2	a	a	B-NP	DT	O	5	NMOD	0
3	human	human	I-NP	JJ	B-protein	5	NMOD	0
4	recombinant	recombinant	I-NP	JJ	I-protein	5	NMOD	0
5	antibody	antibody	I-NP	NN	I-protein	24	NMOD	0
6	(	(	O	(	O	8	DEP	0
7	scFv	scFv	B-NP	NN	O	8	DEP	0
8	)	)	O	)	O	5	NMOD	0
9	specific	specific	B-ADJP	JJ	O	5	NMOD	0
10	for	for	B-PP	IN	O	9	AMOD	0
11	the	the	B-NP	DT	O	15	NMOD	0
12	angiogenesis	angiogenesis	I-NP	NN	O	15	NMOD	3	angiogenesis
13	marker	marker	I-NP	NN	O	15	NMOD	0
14	domain	domain	I-NP	NN	O	15	NMOD	0
15	B	B	I-NP	NN	O	10	PMOD	0
16	of	of	B-PP	IN	O	15	NMOD	0
17	fibronectin	fibronectin	B-NP	NN	B-protein	16	PMOD	0
18	,	,	O	,	O	24	P	0
19	interleukin	interleukin	B-NP	NN	B-protein	24	NMOD	0
20	2	2	I-NP	CD	I-protein	19	NMOD	0
21	,	,	O	,	O	24	P	0
22	and	and	O	CC	O	24	NMOD	0
23	an	an	B-NP	DT	O	24	NMOD	0
24	scFv	scFv	I-NP	NN	O	1	OBJ	0
25	able	able	B-ADJP	JJ	O	24	NMOD	0
26	to	to	B-VP	TO	O	27	VMOD	0
27	neutralize	neutralize	I-VP	VB	O	25	AMOD	18	neutralize
28	tumor	tumor	B-NP	NN	B-protein	30	NMOD	0
29	necrosis	necrosis	I-NP	NN	I-protein	30	NMOD	0
30	factor-alpha	factor-alpha	I-NP	NN	I-protein	27	OBJ	0
31	,	,	O	,	O	33	P	0
32	we	we	B-NP	PRP	O	33	SUB	0
33	expressed	express	B-VP	VBD	O	0	ROOT	0
34	various	various	B-NP	JJ	O	36	AMOD	0
35	biologically	biologically	I-NP	RB	O	36	AMOD	0
36	active	active	I-NP	JJ	O	39	NMOD	0
37	uteroglobin	uteroglobin	I-NP	NN	B-protein	39	NMOD	0
38	fusion	fusion	I-NP	NN	I-protein	39	NMOD	0
39	proteins	protein	I-NP	NNS	I-protein	33	OBJ	0
40	.	.	O	.	O	33	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	results	result	I-NP	NNS	O	3	SUB	0
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	0
4	the	the	B-NP	DT	O	5	NMOD	0
5	possibility	possibility	I-NP	NN	O	20	NMOD	0
6	to	to	B-VP	TO	O	7	VMOD	0
7	generate	generate	I-VP	VB	O	5	NMOD	0
8	monospecific	monospecific	B-NP	JJ	O	12	NMOD	0
9	divalent	divalent	I-NP	JJ	O	12	NMOD	0
10	and	and	I-NP	CC	O	12	NMOD	0
11	tetravalent	tetravalent	I-NP	JJ	B-protein	12	NMOD	0
12	antibodies	antibody	I-NP	NNS	I-protein	7	OBJ	0
13	,	,	O	,	O	20	P	0
14	immunocytokines	immunocytokine	B-NP	NNS	B-protein	20	NMOD	0
15	,	,	O	,	O	20	P	0
16	and	and	O	CC	O	20	NMOD	0
17	dual	dual	B-NP	JJ	O	20	NMOD	0
18	specificity	specificity	I-NP	NN	O	20	NMOD	0
19	tetravalent	tetravalent	I-NP	JJ	O	20	NMOD	0
20	antibodies	antibody	I-NP	NNS	O	3	OBJ	0
21	.	.	O	.	O	3	P	0

1	Furthermore	Furthermore	B-ADVP	RB	O	19	VMOD	0
2	,	,	O	,	O	19	P	0
3	compared	compare	B-PP	VBN	O	19	VMOD	0
4	with	with	B-PP	IN	O	3	PMOD	0
5	similar	similar	B-NP	JJ	O	7	NMOD	0
6	fusion	fusion	I-NP	NN	B-protein	7	NMOD	0
7	proteins	protein	I-NP	NNS	I-protein	4	PMOD	0
8	in	in	B-PP	IN	O	7	NMOD	0
9	which	which	B-NP	WDT	O	8	PMOD	0
10	uteroglobin	uteroglobin	B-NP	NN	O	11	SUB	0
11	was	be	B-VP	VBD	O	8	SBAR	0
12	not	not	I-VP	RB	O	11	VMOD	0
13	used	use	I-VP	VBN	O	11	VC	0
14	,	,	O	,	O	19	P	0
15	the	the	B-NP	DT	O	16	NMOD	0
16	use	use	I-NP	NN	O	19	SUB	0
17	of	of	B-PP	IN	O	16	NMOD	0
18	uteroglobin	uteroglobin	B-NP	NN	O	17	PMOD	0
19	improved	improve	B-VP	VBD	O	0	ROOT	0
20	properties	property	B-NP	NNS	O	19	OBJ	0
21	of	of	B-PP	IN	O	20	NMOD	0
22	solubility	solubility	B-NP	NN	O	24	NMOD	0
23	and	and	I-NP	CC	O	24	NMOD	0
24	stability	stability	I-NP	NN	O	21	PMOD	0
25	.	.	O	.	O	19	P	0

1	Indeed	Indeed	B-ADVP	RB	O	8	VMOD	0
2	,	,	O	,	O	8	P	0
3	in	in	B-PP	IN	O	8	VMOD	0
4	the	the	B-NP	DT	O	6	NMOD	0
5	reported	report	I-NP	VBN	O	6	NMOD	0
6	cases	case	I-NP	NNS	O	3	PMOD	0
7	it	it	B-NP	PRP	O	8	SUB	0
8	was	be	B-VP	VBD	O	0	ROOT	0
9	possible	possible	B-ADJP	JJ	O	8	PRD	0
10	to	to	B-VP	TO	O	11	VMOD	0
11	vacuum	vacuum	I-VP	VB	O	8	VMOD	0
12	dry	dry	B-NP	JJ	O	11	OBJ	0
13	and	and	O	CC	O	11	VMOD	0
14	reconstitute	reconstitute	B-VP	VB	O	11	VMOD	0
15	the	the	B-NP	DT	O	16	NMOD	0
16	proteins	protein	I-NP	NNS	O	14	OBJ	0
17	without	without	B-PP	IN	O	14	VMOD	0
18	any	any	B-NP	DT	O	21	NMOD	0
19	aggregation	aggregation	I-NP	NN	O	21	NMOD	0
20	or	or	I-NP	CC	O	21	NMOD	0
21	loss	loss	I-NP	NN	O	17	PMOD	0
22	in	in	B-PP	IN	O	21	NMOD	0
23	protein	protein	B-NP	NN	O	26	NMOD	0
24	and	and	O	CC	O	26	NMOD	0
25	biological	biological	B-NP	JJ	O	26	NMOD	0
26	activity	activity	I-NP	NN	O	22	PMOD	0
27	.	.	O	.	O	8	P	0

